Stockscreener 앱 받기
85.75
0.35%
0.30
전일 마감가:
$85.45
열려 있는:
$85.36
하루 거래량:
879.01K
Relative Volume:
0.54
시가총액:
$41.61B
수익:
$9.93B
순이익/손실:
$1.12B
주가수익비율:
38.11
EPS:
2.25
순현금흐름:
$1.58B
1주 성능:
-2.41%
1개월 성능:
-1.49%
6개월 성능:
-4.25%
1년 성능:
-7.19%
1일 변동 폭
$85.24
$85.87
1주일 범위
$83.60
$88.01
52주 변동 폭
$80.48
$101.10
Alcon Inc Stock (ALC) Company Profile
ALC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 재확인 | BTIG Research | Buy |
| 2025-03-28 | 재확인 | Needham | Buy |
| 2025-03-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-24 | 재확인 | Needham | Buy |
| 2025-01-10 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 재확인 | Needham | Buy |
| 2024-11-12 | 재확인 | Needham | Buy |
| 2024-10-10 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 개시 | Goldman | Buy |
| 2024-03-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 개시 | Bernstein | Outperform |
| 2023-12-18 | 다운그레이드 | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-10 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | 업그레이드 | Societe Generale | Sell → Hold |
| 2022-12-22 | 개시 | Mizuho | Buy |
| 2022-11-17 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2022-08-11 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-05-12 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-11 | 개시 | BofA Securities | Buy |
| 2022-01-18 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 개시 | Oppenheimer | Perform |
| 2021-07-14 | 개시 | Deutsche Bank | Buy |
| 2021-05-06 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-03-22 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-11-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-07-06 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-07-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-04-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Argus | Hold → Buy |
| 2020-03-24 | 업그레이드 | Societe Generale | Sell → Hold |
| 2020-03-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-26 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-01-08 | 개시 | Argus | Hold |
| 2019-10-29 | 개시 | Stephens | Equal-Weight |
| 2019-08-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-06-24 | 개시 | SVB Leerink | Mkt Perform |
| 2019-06-14 | 개시 | BTIG Research | Neutral |
| 2019-05-10 | 개시 | Robert W. Baird | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
모두보기
Alcon Inc 주식(ALC)의 최신 뉴스
STAAR Surgical's largest holder demands books, records on Alcon deal - MSN
STAAR Surgical's largest holder demands books, records on Alcon deal (update) (STAA:NASDAQ) - Seeking Alpha
Kepler Capital Maintains Buy Rating on Alcon with CHF86.00 Price Target - AInvest
RxSight (RXST) Q2 Loss Beats Estimates - The Motley Fool
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
Assessing the STAAR Surgical-Alcon Deal: Is the $28-Per-Share Offer a Bargain or a Missed Opportunity? - AInvest
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical - Yahoo Finance
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition By Investing.com - Investing.com Australia
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition - Investing.com
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
STAAR Surgical Sale to Alcon Raises Concerns Among Investors - AInvest
Alcon to Acquire STAAR Surgical in $1.5 Billion Deal - The Globe and Mail
Alcon agrees to acquire STAAR Surgical - Ophthalmology Times
Bright move: Alcon offers $1.5B for Staar Surgical - BioWorld MedTech
Alcon to acquire STAAR Surgical - Eyes On Eyecare
STAAR Surgical stock rating downgraded to Neutral by Sidoti on Alcon deal - Investing.com
Alcon to Acquire Staar Surgical for $1.5B - Orange County Business Journal
Alcon agrees to acquire STAAR Surgical for $1.5 billion equity value - MLex
Alcon to acquire STAAR Surgical for about $1.5B - MedTech Dive
STAAR Surgical stock soars after Alcon announces $1.5B acquisition By Investing.com - Investing.com Canada
Why Is STAAR Surgical Stock Skyrocketing Tuesday?Staar Surgical (NASDAQ:STAA), Alcon (NYSE:ALC) - Benzinga
Alcon to Buy STAAR Surgical for $1.5 Billion - Medical Product Outsourcing
Staar Surgical Stock (STAA) Soars on $1.5B Alcon Deal - TipRanks
Staar Surgical Merges with Alcon in $1.5B Deal - TipRanks
First Look: PG&E Surges, Intel Downgraded, and Alcon Acquires ST - GuruFocus
Alcon to Acquire STAAR Surgical for $1.5 Billion - TipRanks
Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical - Yahoo Finance
Alcon Buys STAAR Surgical To Expand Eye Care Portfolio - Finimize
Why Did STAAR Surgical Soar 46.02%? Alcon Acquisition - AInvest
Alcon to buy STAAR Surgical for $1.5 billion - breakingthenews.net
Alcon to buy eye health firm STAAR Surgical for $1.5 bln - Investing.com Canada
Alcon Agrees to Acquire STAAR Surgical - Business Wire
Alcon Inc. Sees Relief Buying After Extended DropBuy Alerts With Low Risk Confirmation Noted - metal.it
How does Alcon Inc. generate profit in a changing economyConsistent high-performance stocks - Jammu Links News
What catalysts could drive Alcon Inc. stock higher in 2025Get daily expert analysis on top stocks - Jammu Links News
What markets is Alcon Inc. expanding into Is TECX stock a good long term investment optionGrow your portfolio with growth-oriented stocks - Jammu Links News
What analysts say about Alcon Inc. stockRemarkable growth - Jammu Links News
What institutional investors are buying Alcon Inc. stockAccelerated investment success - Jammu Links News
Is it the right time to buy Alcon Inc. stockSkyrocketing profit margins - Jammu Links News
What drives Alcon Inc. stock priceCapitalize on market momentum for maximum gains - Jammu Links News
What is the dividend policy of Alcon Inc. stockBuild a portfolio that outperforms the market - Jammu Links News
What are the latest earnings results for Alcon Inc.Triple-digit wealth increases - Jammu Links News
What is the risk reward ratio of investing in Alcon Inc. stockUnlock powerful trading signals for profits - Jammu Links News
What are the technical indicators suggesting about Alcon Inc.Invest smarter with daily stock recommendations - Jammu Links News
Stifel Reaffirms Buy on Alcon (ALC), Highlights Eye Care Leader’s Growth Potential - MSN
What markets is PTC Inc. expanding into Is Alcon Inc. stock a good long term investment optionExpert Picks Signals To Watch Now - Jammu Links News
11 Best Medical Stocks to Buy According to Analysts - Insider Monkey
Alcon (ALC) Stock Price, News & Analysis - MarketBeat
Alcon's (VTX:ALC) investors will be pleased with their notable 31% return over the last five years - simplywall.st
Alcon to acquire LumiThera for dry AMD treatment device - MSN
Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health - Yahoo Finance
Alcon Inc (ALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
자본화:
|
볼륨(24시간):